ATE412761T1 - Methode um rekombinante proteine in cho zellen zu exprimieren - Google Patents

Methode um rekombinante proteine in cho zellen zu exprimieren

Info

Publication number
ATE412761T1
ATE412761T1 AT03765075T AT03765075T ATE412761T1 AT E412761 T1 ATE412761 T1 AT E412761T1 AT 03765075 T AT03765075 T AT 03765075T AT 03765075 T AT03765075 T AT 03765075T AT E412761 T1 ATE412761 T1 AT E412761T1
Authority
AT
Austria
Prior art keywords
cho cells
recombinant proteins
express recombinant
express
enhancing
Prior art date
Application number
AT03765075T
Other languages
English (en)
Inventor
Robert Kallmeier
Robert Gay
Original Assignee
Lonza Biologics Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9940670&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE412761(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lonza Biologics Plc filed Critical Lonza Biologics Plc
Application granted granted Critical
Publication of ATE412761T1 publication Critical patent/ATE412761T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03765075T 2002-07-18 2003-07-21 Methode um rekombinante proteine in cho zellen zu exprimieren ATE412761T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0216648.6A GB0216648D0 (en) 2002-07-18 2002-07-18 Method of expressing recombinant protein in CHO cells
PCT/EP2003/007946 WO2004009823A1 (en) 2002-07-18 2003-07-21 Method of expressing recombinant protein in cho cells

Publications (1)

Publication Number Publication Date
ATE412761T1 true ATE412761T1 (de) 2008-11-15

Family

ID=9940670

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03765075T ATE412761T1 (de) 2002-07-18 2003-07-21 Methode um rekombinante proteine in cho zellen zu exprimieren

Country Status (14)

Country Link
US (3) US20060003405A1 (de)
EP (1) EP1525320B1 (de)
CN (1) CN1296486C (de)
AT (1) ATE412761T1 (de)
AU (2) AU2003251434B2 (de)
CA (2) CA2489016C (de)
DE (1) DE60324430D1 (de)
DK (1) DK1525320T3 (de)
ES (1) ES2314248T3 (de)
GB (1) GB0216648D0 (de)
HK (1) HK1081595A1 (de)
PT (1) PT1525320E (de)
SI (1) SI1525320T1 (de)
WO (1) WO2004009823A1 (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0216648D0 (en) * 2002-07-18 2002-08-28 Lonza Biologics Plc Method of expressing recombinant protein in CHO cells
GB0319451D0 (en) * 2003-08-19 2003-09-17 Lonza Biologics Plc Tropolone assay
EP2404935A1 (de) 2004-03-30 2012-01-11 Glaxo Group Limited Immunglobuline gegen menschlisches OSM
TWI307630B (en) 2004-07-01 2009-03-21 Glaxo Group Ltd Immunoglobulins
AU2006237193B2 (en) * 2005-04-22 2012-02-02 Lonza Biologics Plc. Mammalian expression vector comprising the mCMV promoter and first intron of hCMV major immediate early gene
US20090215165A1 (en) * 2005-05-20 2009-08-27 James Rance High-level expression of recombinant antibody in a mammalian host cell
BRPI0613770A2 (pt) 2005-07-22 2009-05-19 Y S Therapeutics Co Ltd anticorpos anti-cd26 e métodos de uso destes
US9884899B2 (en) 2007-07-06 2018-02-06 Promedior, Inc. Methods for treating fibrosis using CRP antagonists
PL3327026T3 (pl) 2007-07-09 2020-02-28 Genentech, Inc. Zapobieganie redukcji wiązań disiarczkowych podczas rekombinacyjnego wytwarzania polipeptydów
AR074777A1 (es) 2008-12-19 2011-02-09 Glaxo Group Ltd Proteinas de union a antigeno
PT2405928T (pt) 2009-03-11 2017-02-07 Promedior Inc Métodos de tratamento e de diagnóstico para patologias de hipersensibilidade
DK2405929T3 (en) 2009-03-11 2018-08-27 Promedior Inc SAP polypeptide for use in the treatment of autoimmune disorders and graft-versus-host disease
UA110323C2 (en) 2009-06-04 2015-12-25 Promedior Inc Derivative of serum amyloid p and their receipt and application
DK2987803T3 (en) 2009-06-17 2018-12-17 Promedior Inc SAP variants and their application
KR101822205B1 (ko) 2009-08-11 2018-01-25 제넨테크, 인크. 글루타민-비함유 세포 배양 배지에서의 단백질의 생성
WO2011080050A2 (en) 2009-12-11 2011-07-07 Novartis Ag Binding molecules
EP2528947A4 (de) 2010-01-28 2013-09-18 Glaxo Group Ltd Cd127-bindende proteine
MY171234A (en) 2010-02-24 2019-10-04 Immunogen Inc Folate receptor 1 antibodies and immunoconjugates and uses thereof
UA108227C2 (xx) 2010-03-03 2015-04-10 Антигензв'язуючий білок
RU2610662C9 (ru) 2010-03-12 2017-07-24 Иммьюноджен, Инк. Cd37-связывающие молекулы и их иммуноконъюгаты
AR081556A1 (es) 2010-06-03 2012-10-03 Glaxo Group Ltd Proteinas de union al antigeno humanizadas
EP2596027A1 (de) 2010-07-22 2013-05-29 GlaxoSmithKline Biologicals S.A. Neuartige antigenbindende proteine
WO2012019024A2 (en) 2010-08-04 2012-02-09 Immunogen, Inc. Her3-binding molecules and immunoconjugates thereof
AU2012275133B2 (en) 2011-06-30 2017-08-17 Genzyme Corporation Inhibitors of T-cell activation
RU2014101669A (ru) 2011-07-15 2015-09-20 Онкомед Фармасьютикалс, Инк. Агенты, связывающие белки r-спондины (rspo), и способы их применения
EP2734232B1 (de) 2011-07-19 2017-11-01 Philogen S.p.A. Sequentielle anti-ctla4 und zielgerichtete il-2 therapie
UY34317A (es) 2011-09-12 2013-02-28 Genzyme Corp Anticuerpo antireceptor de célula T (alfa)/ß
CN107722122B (zh) 2011-09-23 2022-05-27 昂考梅德药品有限公司 Vegf/dll4结合剂及其应用
BR112014012539B1 (pt) 2011-11-23 2022-12-20 Medimmune, Llc Anticorpo que se liga especificamente a her3, composição compreendendo o mesmo, e usos do anticorpo
EP2858673A4 (de) 2012-06-06 2016-06-22 Oncomed Pharm Inc Bindungsmittel zur modulation des hippo-pfads und verwendungen davon
EP2674495A1 (de) * 2012-06-14 2013-12-18 Sanofi CHO-Expressionssystem
NZ704269A (en) 2012-07-13 2016-05-27 Oncomed Pharm Inc Rspo3 binding agents and uses thereof
NZ726258A (en) 2012-08-31 2019-07-26 Immunogen Inc Antibodies and uses thereof to detect folate receptor 1
EP2711426B1 (de) 2012-09-24 2015-04-08 Lonza Biologics plc Expressionsvektoren mit chimärem Cytomegalieviruspromotor und Verstärkersequenzen
KR20150090919A (ko) 2012-12-04 2015-08-06 온코메드 파마슈티칼스, 인크. 결합제를 사용한 면역요법
WO2014100073A2 (en) * 2012-12-21 2014-06-26 Merck Sharp & Dohme Corp. Expression vectors for recombinant protein production in mammalian cells
KR20230145514A (ko) 2013-08-30 2023-10-17 이뮤노젠 아이엔씨 엽산 수용체 1의 검출을 위한 항체 및 분석
US10203327B2 (en) 2013-11-05 2019-02-12 Novartis Ag Organic compounds
TW201610168A (zh) 2013-12-02 2016-03-16 安可美德藥物股份有限公司 與Ｗｎｔ途徑抑制劑有關之預測性生物標記之鑑別
EP3099713B1 (de) 2014-02-02 2020-01-15 MedImmune Limited Chimäres proteins bestehtend aus einer ngf antagonist und einer tnfa antagonist domaine
US8961992B1 (en) * 2014-04-02 2015-02-24 Tunitas Therapeutics, Inc. Epsigam fusion protein
DK3128997T3 (da) 2014-04-08 2020-08-24 Boston Pharmaceuticals Inc Bindingmolekyler specifikke for il-21 og anvendelser deraf
CA2943299A1 (en) 2014-04-11 2015-10-15 Medimmune, Llc Bispecific her2 antibodies
WO2015165480A1 (en) 2014-04-30 2015-11-05 Institute For Research In Biomedicine Human cytomegalovirus vaccine compositions and method of producing the same
CN106456734A (zh) 2014-05-29 2017-02-22 免疫医疗有限责任公司 Ox40l融合蛋白及其用途
AU2015289386A1 (en) * 2014-07-18 2017-03-09 Celltheon Corporation Methods and compositions for expression of polypeptides in a cell
CN104195173B (zh) * 2014-09-02 2017-03-08 北京比洋生物技术有限公司 具有双表达盒的谷氨酰胺合成酶高效表达载体
TW201619200A (zh) 2014-10-10 2016-06-01 麥迪紐有限責任公司 人類化抗－ｏｘ４０抗體及其用途
WO2016059602A2 (en) 2014-10-16 2016-04-21 Glaxo Group Limited Methods of treating cancer and related compositions
DK3218406T3 (da) 2014-11-10 2021-06-21 Medimmune Ltd Bindingsmolekyler, der er specifikke for cd73, og anvendelser deraf
US20160129108A1 (en) 2014-11-11 2016-05-12 Medimmune Limited Therapeutic combinations comprising anti-cd73 antibodies and uses thereof
CN104561091A (zh) * 2014-12-17 2015-04-29 华南理工大学 一种光学分析检测cho细胞增殖的方法及应用
CN105779501A (zh) * 2014-12-26 2016-07-20 上海药明康德新药开发有限公司 运用cho宿主细胞进行重组蛋白的瞬时表达生产的方法
CN105802995A (zh) * 2014-12-31 2016-07-27 上海复宏汉霖生物技术有限公司 一种利用cho细胞生产重组蛋白的基因表达系统及真核表达载体
CN107206079A (zh) 2015-01-09 2017-09-26 免疫医疗有限责任公司 检测人dpp‑4的测定法
CN107849111B (zh) 2015-05-04 2022-02-22 Vcn生物科学有限公司 在免疫显性腺病毒抗原表位中具有突变的溶瘤腺病毒及其在癌症治疗中的用途
EP3313884B9 (de) 2015-06-29 2021-05-19 ImmunoGen, Inc. Anti-cd123-antikörper und wirkstoffe und derivate davon
MX2018001787A (es) 2015-08-12 2018-06-06 Medimmune Ltd Proteinas de fusion del ligando de la proteina relacionada con el receptor de factor de necrosis tumoral inducido por glucorticoides (gitrl) y usos de las mismas.
JP6967003B2 (ja) 2015-09-23 2021-11-17 メレオ バイオファーマ ５ インコーポレイテッド がんの処置のための方法および組成物
IL258538B2 (en) 2015-10-09 2023-04-01 Genzyme Corp Early isolation after the infection of cells (epic) for the production of biological material
WO2017083451A1 (en) 2015-11-10 2017-05-18 Medimmune, Llc Binding molecules specific for asct2 and uses thereof
AU2017230091B2 (en) 2016-03-10 2022-04-07 Acceleron Pharma Inc. Activin type 2 receptor binding proteins and uses thereof
US10913783B2 (en) 2016-04-15 2021-02-09 H. Lundbeck A/S Humanized anti-PACAP antibodies and uses thereof
CA3025377A1 (en) 2016-06-02 2017-12-07 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
AU2017341028B2 (en) 2016-10-07 2023-12-21 Genzyme Corporation Early post-transfection isolation of cells (EPIC) for biologics production
US11186626B2 (en) 2016-10-11 2021-11-30 Integrated Biotherapeutics, Inc. Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop
CN110662770A (zh) 2016-11-23 2020-01-07 比奥维拉迪维治疗股份有限公司 结合凝血因子ix和凝血因子x的双特异性抗体
CN107973841B (zh) * 2016-12-23 2022-03-25 浙江海隆生物科技有限公司 Cho细胞表达的重组牛病毒性腹泻病毒e2蛋白及亚单位疫苗的制备方法和应用
CN111372946A (zh) 2017-02-17 2020-07-03 隆萨有限公司 难以表达的蛋白质的多位点特异性整合细胞
GB201703418D0 (en) 2017-03-03 2017-04-19 Ge Healthcare Bio Sciences Ab Method for cell line development
CN110785494A (zh) 2017-06-16 2020-02-11 隆萨有限公司 用于生产生物制品的通用自调节哺乳动物细胞系平台
RU2020117698A (ru) 2017-12-01 2022-01-04 Эббви Инк. Агонист глюкокортикоидного рецептора и его иммуноконъюгаты
JP2022516505A (ja) 2018-12-28 2022-02-28 スパークス・セラピューティクス・インコーポレイテッド 癌および他の疾患の治療のための、クローディン１８．２に特異的な結合分子、その組成物および方法
AU2020253455A1 (en) 2019-04-03 2021-11-04 Genzyme Corporation Anti-alpha beta TCR binding polypeptides with reduced fragmentation
KR20220037435A (ko) 2019-06-18 2022-03-24 유나이티드 쎄러퓨틱스 코포레이션 이식용 장기의 미토콘드리아 처리
CN113005140B (zh) * 2019-12-19 2024-03-15 鲁南制药集团股份有限公司 一种具有双表达盒的gs表达载体及其应用
WO2021251340A1 (ja) 2020-06-08 2021-12-16 ワイズ・エー・シー株式会社 抗癌剤への抵抗性改善剤
BR112023004840A2 (pt) 2020-09-28 2023-04-18 Medimmune Ltd Compostos e métodos para tratamento de dor
JP2022184105A (ja) 2021-05-31 2022-12-13 ワイズ・エー・シー株式会社 抗ｃｄ２６抗体と免疫チェックポイント阻害剤との併用療法
US11807685B2 (en) 2021-08-05 2023-11-07 The Uab Research Foundation Anti-CD47 antibody and uses thereof
WO2023064947A1 (en) 2021-10-15 2023-04-20 Regenxbio Inc. Antibodies and methods of using thereof
US20240101691A1 (en) 2022-09-21 2024-03-28 Sanofi Biotechnology Humanized anti-il-1r3 antibody and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2944850A1 (de) * 1979-11-07 1981-05-27 Bayer Ag, 5090 Leverkusen Mittel zur regulierung des pflanzenwachstums, deren herstellung und deren verwendung
US4968615A (en) 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
US4963481A (en) * 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US5891693A (en) * 1990-01-25 1999-04-06 Alusuisse Holdings A.G. Recombinant DNA methods vectors and host cells
IT1262545B (it) 1993-10-25 1996-07-02 Menarini Ricerche Sud S P A A Sistema di espressione per linee cellulari eucariotiche
DK0731845T3 (da) * 1993-12-23 2003-10-20 Merck & Co Inc Homologt rekombinant antistofekspressionssystem til murine celler
AU684134B2 (en) 1994-02-07 1997-12-04 Qiagen Gmbh Nucleic acid transfection efficiency increase by use of isopropanol in aqueous solutions
GB0216648D0 (en) * 2002-07-18 2002-08-28 Lonza Biologics Plc Method of expressing recombinant protein in CHO cells
ATE399872T1 (de) 2003-03-11 2008-07-15 Serono Lab Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten

Also Published As

Publication number Publication date
CA2672809C (en) 2013-01-08
CN1668749A (zh) 2005-09-14
US20080138902A1 (en) 2008-06-12
US7932087B2 (en) 2011-04-26
AU2009200665A1 (en) 2009-03-12
DK1525320T3 (da) 2009-02-23
CN1296486C (zh) 2007-01-24
GB0216648D0 (en) 2002-08-28
CA2672809A1 (en) 2004-01-29
AU2009200665B2 (en) 2012-08-16
ES2314248T3 (es) 2009-03-16
HK1081595A1 (en) 2006-05-19
EP1525320A1 (de) 2005-04-27
SI1525320T1 (sl) 2009-02-28
EP1525320B1 (de) 2008-10-29
CA2489016A1 (en) 2004-01-29
DE60324430D1 (de) 2008-12-11
WO2004009823A1 (en) 2004-01-29
AU2003251434A1 (en) 2004-02-09
US20060003405A1 (en) 2006-01-05
US20110104745A1 (en) 2011-05-05
PT1525320E (pt) 2009-01-23
CA2489016C (en) 2012-01-17
AU2003251434B2 (en) 2009-03-05

Similar Documents

Publication Publication Date Title
DE60324430D1 (de) Methode um rekombinante proteine in cho zellen zu exprimieren
ATE437652T1 (de) Verwendung von hmgb1 zur aktivierung dendritischer zellen
CY1118782T1 (el) Επιλογη κυτταρων που εκφραζουν ετερομερη πολυπεπτιδια
BR112012015255A2 (pt) "anticorpo, composição farmaceutica, uso de um anticorpo,método de tramento ,ácido nucleico, vetor de espressão, célula hospedeira e método de produção de um anticorpo recobinante"
BRPI0411475A (pt) adições de código genético de aminoácido reativo não natural
DK1720979T3 (da) Anvendelse af et serumfrit celledyrkningsmedium til fremstilling af IL-18BP I pattedyrceller
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
CY1110734T1 (el) Μεθοδος παραγωγης μονιμων ανθρωπινων κυτταρικων σειρων
MX2010001319A (es) Metodo para producir proteinas heterogeneas.
NO20076087L (no) Serum-fri stabil transfeksjon og fremstilling av rekombinante humane proteiner i humane cellelinjer
NO20052276D0 (no) Sirkulaert DNA-molekyl med en kondisjonell replikasjonsorigo, fremgangsmate for deres fremstilling og deres anvendelse i genterapi
ATE527349T1 (de) Nervenregeneration
SG156690A1 (en) Mammalian genes involved in infection
DK1697523T3 (da) Ekspressionsvektor til antibiotikafri ekspression
WO2005003315A3 (en) Compositions and methods for peptide-assisted transfection
ATE488591T1 (de) Neuer l-lysin-induzierbarer promotor
CY1111769T1 (el) Παρασκευη κυτταρων
EA202091349A1 (ru) Способы культивирования клеток
ATE474926T1 (de) Verwendung von clya hemolysin fur ausscheidung von fusionprotein
DK1495112T3 (da) Cellekulturmedium
DK2010565T3 (da) Fremgangsmåde til produktion af rekombinant protein i CHO-celler
SG146623A1 (en) Rodent expression systems utilising polyoma virus and epstein barr virus sequences
KR100717353B1 (ko) 피키아 파스토리스 유래의 자동 유도성 ｎｐｓ 프로모터 및이를 이용한 이종 단백질의 제조방법
DK1626992T3 (da) Produktion af rekombinant IgM i PER.C6-celler
DK1572133T3 (da) Fremgangsmåde til identificering af modulatorer af den humane orexin-2-receptor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1525320

Country of ref document: EP